Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Bass, Berry & Sims’ returned 818 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    2024 Healthcare Private Equity Outlook & Trends

    With various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    OIG Offers Guidance For ASCs When Physician-Investors Fail The One-Third Income Test

    Nearly 25 years ago, the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS) created a regulatory safe harbor
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
Article

Reminder – Annual Deadline (July 31) To Report And Pay PCORI Fee Is Approaching

The PCORI fee for the 2025 plan year is due July 31, 2026, with the rate increasing to $3.84 per covered life. Understanding who must file—insurers for insured plans versus plan sponsors for self-insured arrangements—and which health plans are subject to this annual excise tax filing is critical for compliance. This guide clarifies the filing obligations, calculation methods, and special considerations for integrated HRA plans.
United StatesTax
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
  • Article

    The Time Is Here: Public Companies Should Be Mindful Of The Upcoming Insider Trading Policy Form 10-K Exhibit Filing Requirement

    In connection with the upcoming Form 10-K/proxy season, public companies with a fiscal year ending on December 31 will be required, for the first time, to publicly file their insider trading policies as exhibits...
    United StatesCorporate/Commercial Law
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    CMS Finalizes RPM And RTM Changes, Delays Direct-Employee Staffing Rule To 2029

    The Centers for Medicare & Medicaid Services has issued sweeping changes to remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) billing requirements, fundamentally reshaping how physician practices can deliver and bill for these services. While some provisions take effect in 2027, the most significant change—requiring clinical staff to be direct employees rather than third-party contractors—has been delayed until 2029, giving the industry critical time to restructure existing
    United StatesFinance and Banking
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    CMS Bolsters Primary Care With Advanced Primary Care Management Coverage

    On November 1, the Centers for Medicare & Medicaid Services (CMS) filed its Medicare Physician Fee Schedule (PFS) final rule (Final Rule) for calendar year (CY) 2025. As part of the Final Rule.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    Supply Chain AI Needs More Than Automation. It Needs Guardrails

    As artificial intelligence increasingly automates supply chain decisions—from supplier approvals to contract execution—companies face mounting legal and compliance risks without proper governance frameworks. Existing consumer protection laws still apply to AI-driven business decisions, meaning organizations cannot outsource accountability to algorithms. Legal experts outline essential guardrails including human oversight thresholds, regular testing protocols, and documentation practices that ena
    United StatesCorporate/Commercial Law
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    Federal Appeals Court Upholds Bargaining Order, Sidesteps Review Of NLRB’s Cemex Standard

    The Ninth Circuit upheld a bargaining order against Cemex Construction Materials under the long-standing Gissel standard, finding that the employer’s “pervasive” unfair labor practices, including threats of plant...
    United StatesEmployment and HR
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    CMS Finalizes CY 2025 Medicare Advantage Rule, Confirming Continued Focus On Marketing Practices And Health Equity

    On April 4, the Centers for Medicare & Medicaid Services (CMS) issued the Contract Year (CY) 2025 Medicare Advantage (MA) Final Rule (Final Rule)...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    How To Comply With Stage One Of The Laboratory Developed Tests Final Rule

    The move by the Food and Drug Administration (FDA) to regulate Laboratory Developed Tests (LDTs) as medical devices presents new obligations for an industry historically shielded from regulatory enforcement.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    Smoke Is Not Fire: Fourth Circuit Rejects Stark And AKS Theories Built On Ordinary Business Practices And Conclusory Allegations

    The Fourth Circuit held that physician compensation tied to the physician’s wRVUs is based on the physician’s own productivity, not the volume or value of referrals, and therefore does not inherently violate the Stark...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    DoD Publishes Proposed Rule To Amend DFARS Provisions Related To The CMMC 2.0 Program

    On August 15, the Department of Defense (DoD) published a proposed rule to amend the Defense Federal Acquisition Regulation Supplement (DFARS) to incorporate contractual requirements related to the proposed Cybersecurity Maturity Model Certification (CMMC) 2.0 program rule.
    United StatesGovernment, Public Sector
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    Executive Order Directs Systematic Review Of "Covered Contracts And Grants" For Possible Termination

    Over the first month of the new administration, President Trump has directed the review or termination of certain types of contracts and grants, including equity-related agreements...
    United StatesGovernment, Public Sector
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    FinCEN Advisory Warns Financial Institutions Of Healthcare Fraud Targeting Medicare And Medicaid

    At the end of March, the U.S. Treasury Department’s Financial Crimes Enforcement Network (FinCEN) issued a new Advisory urging financial institutions to heighten...
    United StatesGovernment, Public Sector
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    False Claims Act Decisions To Know From Q3 2023

    Below are noteworthy False Claims Act (FCA) decisions from the third quarter of 2023. The main issues in the cases are...
    United StatesLitigation, Mediation & Arbitration
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    CMS CY 2026 Parts C And D Proposals Focus On Informed Choice

    On December 10, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule, which, if finalized as proposed, has potentially significant implications...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    SBIR/STTR Reauthorization Brings New Opportunities And New Diligence Expectations

    After a brief lapse, Congress has reauthorized the Small Business Innovation Research and Small Business Technology Transfer programs through Fiscal Year 2031.
    United StatesGovernment, Public Sector
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    Mitigating The Risk Of Unknown CAM Expenses

    While "common area maintenance" provisions are typically a key topic during lease negotiations, a renewed focus has developed due to changes...
    United StatesReal Estate and Construction
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    DOJ’s First FCPA Deferred Prosecution Agreement Of 2026 Highlights Cartel-Linked Corruption Risks

    The Scoular Company agreed to pay over $10 million to resolve FCPA charges related to bribing Mexican customs officials through third-party brokers, marking the DOJ’s first FCPA deferred prosecution agreement of 2026.
    GlobalCriminal Law
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Article

    D.C. Circuit Upholds FRA Buy America Waiver For Brightline West High-Speed Rail Project

    The D.C. Circuit's recent decision in a Buy America waiver challenge establishes new precedent for how federal agencies evaluate domestic availability in infrastructure projects. The ruling addresses whether manufacturers' future production capabilities should factor into waiver decisions and clarifies the standing requirements for suppliers challenging such waivers. This case provides critical guidance for companies navigating federal procurement requirements in transportation and infrastructure projects.
    GlobalGovernment, Public Sector
    Bass, Berry & Sims PLC
    Bass, Berry & Sims PLC
  • Showing 661–680 of 818 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics